The Food and Drug Administration recently approved a third drug indicated for treatment of fibromyalgia. Milnacipran, made by Forest Laboratories and Cypres Bioscience, is a selective serotonin and norepinephrine dual reuptake inhibitor. It will be available to consumers in March. The two other medicines approved by the FDA for fibromyalgia are Lyrica, produced by Pfizer, and Cymbalta, produced by Lilly. From my perspective there are at least two remarkable features of these approvals.
Dual Reuptake Inhibitor
Featured Health Expert
More information on "Dual Reuptake Inhibitor"
From Our Experts
EXPERT
Treating Anxiety Disorders with Medications
By Jerilyn Ross, M.A., L.I.C.S.W., Health Expert
I consulted Justine Kent, MD, for the latest information about treating anxiety disorders with medications. Dr. Kent is an Adjunct... Read more »
EXPERT
NSAIDs Reduce Effectiveness of Antidepressants
By Karen Lee Richards, Health Expert
Researchers at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University have published the results of their... Read more »
EXPERT
Can Aspirin Decrease the Effectiveness of Your Antidepressant?
By Merely Me, Health Expert
Not so long ago I wrote about a study showing that exposure to aspirin is associated with a reduction in the risk for developing clinical... Read more »
EXPERT
Dual Use of Prescription and Over-the-Counter NSAIDs
By Christine Miller, Health Expert
Nonsteroidal anti inflammatory drugs (NSAIDs) are commonly used to treat the pain and swelling of arthritis and other musculoskeletal... Read more »
EXPERT
Mastering Diabetes: A1c Goals, Dual Wave with Insulin Pumps, Alcohol,...
By Gina Capone, Health Expert
This is Day 2 of a 5 day intensive mastering your diabetes program that I participated in at the Diabetes Research Institute. Please read... Read more »
From Our Sources
Depression Medications, Antidepressants, Suicide Risk
Source: ADAM Encyclopedia
Drug Treatment GuidelinesMajor Classes of Antidepressants and General Treatment GuidelinesMajor classes of antidepressants include:Selective... Read more »
New antidepressants may take place of SSRIs
Selective serotonin-reuptake inhibitors (SSRIs) such as Paxil, Prozac, and Zoloft have been the darlings of the antidepressant market for years. New... Read more »
Antidepressants may endanger fetal health
A new Canadian study suggests that the use of selective serotonin reuptake inhibitors (SSRIs) like Paxil, Zoloft, and Paxil during pregnancy may be... Read more »
ACE Inhibitors May Prevent Dementia
Blood pressure medications in the class known as angiotensin-converting enzyme (ACE) inhibitors appear to reduce the risk of developing Alzheimer's... Read more »
Breast Cancer Hormone Treatment: Tamoxifen, other SERMs, and A...
Source: ADAM Encyclopedia
www.cancer.gov -- National Cancer Institutewww.cancer.org -- American Cancer Societywww.asco.org -- American Society of Clinical... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
